Price T Rowe Associates Inc Gossamer Bio, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 64,777 shares of GOSS stock, worth $84,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,777
Previous 6,434,046
98.99%
Holding current value
$84,857
Previous $6.35 Million
99.07%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
153MCall Options Held
793KPut Options Held
528K-
Octagon Capital Advisors LP New York, NY18.4MShares$24 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$23.7 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.1 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11.5 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.6 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $123M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...